Jamal Musiala's Health Scare: Neurological Diagnosis and Recovery Plans

Jamal Musiala’s latest health scare has jolted Bayern Munich just as their playmaker was trying to piece his career back together.

The 23-year-old collapsed on the pitch for the second time in four days during a friendly win over Heidenheim, sparking immediate alarm. He appeared dazed, required on-field medical treatment and was helped off, a chilling repeat of the incident that had already shaken Bayern in their match against RB Leipzig.

This time, there were answers.

Musiala later released a statement confirming he has been diagnosed with temporary, brief absence seizures caused by a neurological dysfunction. It put a name to the episodes that had left team-mates, staff and supporters stunned in silence.

Inside the club, the situation is being treated with the gravity it demands. Sporting director Max Eberl has made it clear Bayern are fully informed and standing firmly behind their No. 10 as he undergoes further tests and treatment.

In Germany, the images of Musiala’s collapse triggered immediate medical debate. BILD sought the expertise of Prof. Christoph Kleinschnitz, head of neurology at the University Hospital Essen, to help explain what might be happening.

“From a neurological perspective, this could potentially be an epileptic seizure. It could be a form of absence epilepsy, as symptoms such as brief periods of unresponsiveness are consistent with it,” he said, before stressing that a definitive diagnosis rests on the complete set of neurological findings. He underlined two key points: the condition is highly treatable, and with appropriate long-term therapy, Musiala can continue his career.

That last part matters enormously at Säbener Straße.

Musiala is already fighting his way back from a brutal run of injuries. His 2025-26 season was ripped apart by a fractured fibula combined with a dislocated and broken ankle suffered during the Club World Cup against Paris Saint-Germain. Those orthopaedic injuries cost him a significant portion of the campaign and stalled the momentum of one of Europe’s most gifted young playmakers.

Now comes another hurdle, this time neurological rather than structural. The task is twofold: complete rehabilitation from the serious leg injuries and manage a newly diagnosed condition that demands careful, long-term oversight.

The mood around the player, though, is not one of resignation. Medical experts remain confident that with the right treatment plan, these absence seizures will not derail his professional future. Musiala himself has spoken optimistically about adapting his routine and working closely with specialists.

Inside Bayern, the calculation is simple: protect the player first, then think about the football. Yet the football still looms large. The club want their creative hub fully integrated for the coming season as they chase trophies on multiple fronts. His vision, movement and ability to unlock defences remain central to their plans.

For now, his availability rests in the hands of doctors and neurologists rather than coaches. Family, friends and club staff are keeping close as he navigates his treatment and monitoring. The final decision on when he steps back onto the pitch will only come when medical staff are convinced every possible risk has been minimised.

When that green light arrives, the question will not be whether Musiala can still play. It will be how quickly he can turn another setback into the next surge of his career.